Background Females with BRCA 1/2 gene mutations have increased lifetime risk of breast and ovarian cancers. BRCA mutation carriers in NL are not engaging in cancer prevention and screening behaviors according to recommended guidelines. Methods Qualitative interviews were combined with a provincial survey to conduct a comprehensive assessment of BRCA mutation carriers’ opinions towards risk management services. Results Female BRCA mutation carriers’ risk management is influenced by numerous and varied factors including clinical and social influences, family and personal history of cancer, life stage, health system access, and family physicians’ BRCA knowledge and expertise. Individuals were overwhelmingly in support of a centralized and ...
Abstract Background Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for preve...
One in nine women will develop breast cancer in her lifetime (Canadian Cancer Society, 2007). Heredi...
This project seeks to support the clinical practice of using established guidelines for evaluating w...
Background: Breast and ovarian cancer can arise from genetic predisposition and environmental (i.e.,...
Background: Breast and ovarian cancer can arise from genetic predisposition and environmental (i.e.,...
PURPOSE: Women carrying BRCA1/BRCA2 germ-line mutations have an increased risk of developing breast/...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of...
Mutations in the BRCA1 or BRCA2 genes are associated with increased risks for breast, ovarian, and s...
BRCA1 and BRCA2 are gene mutations that drastically increase chances of developing breast and ovaria...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
BRCA1/2 mutation carriers are at a significantly increased risk for breast and ovarian cancer as com...
Background: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative ...
This project seeks to support the clinical practice of using established guidelines for evaluating w...
Abstract Background Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for preve...
One in nine women will develop breast cancer in her lifetime (Canadian Cancer Society, 2007). Heredi...
This project seeks to support the clinical practice of using established guidelines for evaluating w...
Background: Breast and ovarian cancer can arise from genetic predisposition and environmental (i.e.,...
Background: Breast and ovarian cancer can arise from genetic predisposition and environmental (i.e.,...
PURPOSE: Women carrying BRCA1/BRCA2 germ-line mutations have an increased risk of developing breast/...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of...
Mutations in the BRCA1 or BRCA2 genes are associated with increased risks for breast, ovarian, and s...
BRCA1 and BRCA2 are gene mutations that drastically increase chances of developing breast and ovaria...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
BRCA1/2 mutation carriers are at a significantly increased risk for breast and ovarian cancer as com...
Background: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative ...
This project seeks to support the clinical practice of using established guidelines for evaluating w...
Abstract Background Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for preve...
One in nine women will develop breast cancer in her lifetime (Canadian Cancer Society, 2007). Heredi...
This project seeks to support the clinical practice of using established guidelines for evaluating w...